Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-12-28
2000-06-27
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514361, 514385, 514400, 514402, 5462727, 5483127, 5483164, A01N 4350, A01N 4364, A01N 4382, C07D40314, C07D40302
Patent
active
060807695
ABSTRACT:
The present invention relates to compounds of formula 1 ##STR1## and to pharmaceutically acceptable salts and solvates thereof, wherein Z, R, R.sup.3 and R.sup.4 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of inhibiting abnormal cell growth, including cancer, in a mammal by administering the compounds of formula 1 to said mammal.
REFERENCES:
Nancy E. Kohl, et al., "Selective Inhibition of ras-Dependent Transformation by Farnesyltransferase Inhibitor", Science, vol. 260, pp. 1934-1937, (1993).
Lyssikatos Joseph P.
Yang Bingwei V.
Desai Rita
Donahue E. Victor
Ginsburg Paul H.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Imidazolidin-4-one derivatives useful as anticancer agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazolidin-4-one derivatives useful as anticancer agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazolidin-4-one derivatives useful as anticancer agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1785099